90-Day Cancer Mortality

How it works

Risks & contraindications

Comparisons

Highlighted claims

• Swedish-born patients in high migrant density neighbourhoods had a 15% higher rate of 90-day mortality than those in low-density areas pre-pandemic, after full adjustment. — Neighbourhood migrant density and outcomes in hospitalised patients with cancer before and during the COVID-19 pandemic in Sweden: a register-based retrospective cohort study
• During the pandemic the mortality association attenuated for Swedish-born patients but strengthened markedly for Western migrants. — Neighbourhood migrant density and outcomes in hospitalised patients with cancer before and during the COVID-19 pandemic in Sweden: a register-based retrospective cohort study
• No statistically significant association between migrant density and 90-day mortality was found for non-Western migrants before the pandemic, though the interaction test indicated differential patterns across groups. — Neighbourhood migrant density and outcomes in hospitalised patients with cancer before and during the COVID-19 pandemic in Sweden: a register-based retrospective cohort study
• Statistically significant mortality associations with migrant density were primarily concentrated in patients aged 65 and older. — Neighbourhood migrant density and outcomes in hospitalised patients with cancer before and during the COVID-19 pandemic in Sweden: a register-based retrospective cohort study
• Elevated mortality in high migrant density areas persisted after full adjustment for area deprivation, pointing to factors beyond economic disadvantage such as access to palliative care and timely follow-up. — Neighbourhood migrant density and outcomes in hospitalised patients with cancer before and during the COVID-19 pandemic in Sweden: a register-based retrospective cohort study
• Western migrants in high migrant density areas had a 9% higher 90-day mortality rate than those in low-density areas pre-pandemic. — Neighbourhood migrant density and outcomes in hospitalised patients with cancer before and during the COVID-19 pandemic in Sweden: a register-based retrospective cohort study